The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Apple Vision Pro brings relief to macular degeneration patients, with a daughter sharing how it improved her parent’s quality ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ...

photodynamic therapy with verteporfin and surgical treatments. Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

Intermediate AMD: If you have intermediate AMD in one or both eyes, AREDS 2 supplements may help prevent it from turning into late-stage AMD, which causes significant vision loss. Late AMD in One Eye: ...

However, bevacizumab is not currently licensed for neovascular age-related macular degeneration (nAMD). Our study is the first trial-based economic evaluation to evaluate the cost-effectiveness of ...